Bayer and Atara Biotherapeutics in CAR T-cell therapy deal
Bayer and Atara Biotherapeutics have entered a strategic collaboration for mesothelin-targeted CAR T-cell therapies for solid tumors.
Archives for December 7, 2020
Reports from ASH virtual meeting
ASH virtual event hears about CRISPR and CAR-T based approaches to hard-to-treat blood disorders and cancers
Three studies, which are being presented during the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, report promising results in the use of cutting-edge genome editing and cellular therapies for hard-to-treat blood disorders and...
Lilly, UnitedHealth team up on COVID-19 antibody study, US government secures more bamlanivimab doses
UnitedHealth Group is partnering with Eli Lilly and Co to test the efficacy of the Indianapolis-based pharma giant’s COVID-19 monoclonal antibody treatment, bamlanivimab, with patients at the highest risk of adverse outcomes.
CGT industry maturing ‘at a promising rate’ in the UK
New data shows a move towards commercialization and a 48% increase in GMP cell and gene therapy (CGT) manufacturing space in the UK this year despite the COVID-19 pandemic.